Uterine papillary serous carcinoma: study of 19 cases

Objective: Uterine papillary serous carcinoma (UPSC) is an uncommon highly malignant variant of endometrial carcinoma that histologically and clinically resembles ovarian papillary serous carcinoma. The purpose of this study was to present the conjoined experience of two regional hospitals in the so...

Full description

Saved in:
Bibliographic Details
Published in:European journal of obstetrics & gynecology and reproductive biology 1998-07, Vol.79 (1), p.69-73
Main Authors: Piura, Benjamin, Meirovitz, Mihai, Shmulman, Michael, Yanai-Inbar, Ilana, Cohen, Yoram, Dgani, Ram
Format: Article
Language:English
Subjects:
Adjuvant therapy
Adult
Aged
Aged, 80 and over
Animals
Biological and medical sciences
Combined Modality Therapy
Cystadenocarcinoma, Papillary - diagnosis
Cystadenocarcinoma, Papillary - therapy
Endometrial carcinoma
Ethnic Groups
Female
Follow-Up Studies
Humans
Logistic Models
Medical sciences
Middle Aged
Papillary serous carcinoma
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the genital tract and mammary gland
Surgical stage
Survival Rate
Tropical medicine
Uterine Neoplasms - diagnosis
Uterine Neoplasms - therapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective: Uterine papillary serous carcinoma (UPSC) is an uncommon highly malignant variant of endometrial carcinoma that histologically and clinically resembles ovarian papillary serous carcinoma. The purpose of this study was to present the conjoined experience of two regional hospitals in the south of Israel (Soroka Medical Center, Beer-Sheva and Kaplan Hospital, Rehovot) of handling this tumour. Study Design: Data from the files of 19 patients with UPSC who were managed at these hospitals between July 1991 and June 1997 were evaluated. Results: The three-year survival rate was 57.3% overall; 83.3% for Stage I and 21.2% for Stages II, III, and IV combined ( P
ISSN:0301-2115
1872-7654
DOI:10.1016/S0301-2115(98)00039-6